Investing.com UK - Financial Markets Worldwide
⚠ Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

Why Universal Electronics Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Published 17/02/2023, 17:26
© Reuters. Why Universal Electronics Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Friday's Mid-Day Session
IXIC
-
UEIC
-

Benzinga - Gainers

  • Ibio Inc (NYSE: IBIO) shares rose 97% to $1.4787 after the company announced MUC16 as its latest immune-oncology target program.
  • Universal Security Instruments, Inc. (NYSE: UUU) rose 40.6% to $3.09 after the company reported a year-over-year increase in Q3 EPS and revenues.
  • SciSparc Ltd. (NASDAQ: SPRC) gained 25.4% to $1.1410 after the company announced its MitoCareX Bio joint venture achieved achieved its first milestone pursuant to the March 10, 2022 Founders and Investment Agreement.
  • Cyclo Therapeutics, Inc. (NASDAQ: CYTH) surged 22.4% to $1.3952.
  • AMC Networks Inc. (NASDAQ: AMCX) shares jumped 20.9% to $24.60 after reporting better-than-expected Q4 results.
  • EBET, Inc. (NASDAQ: EBET) gained 18.4% to $0.6321 following strong Q4 results and guidance from DraftKings.
  • Apexigen, Inc. (NASDAQ: APGN) jumped 15.8% to $1.10.
  • Telephone and Data Systems, Inc. (NYSE: TDS) rose 15% to $12.80 after the company posted Q4 results and increased its common share dividend from $0.18 to $0.185.
  • Celyad Oncology SA (NASDAQ: CYAD) jumped 14.9% to $1.31.
  • IVERIC bio, Inc. (NASDAQ: ISEE) surged 14.9% to $22.98 after the FDA accepted the company's New Drug Application for avacincaptad pegol.
  • Lanvin Group Holdings Limited (NYSE: LANV) gained 14.7% to $8.20.
  • DraftKings Inc. (NASDAQ: DKNG) shares climbed 14.6% to $20.41 after the company reported better-than-expected Q4 results and raised FY23 guidance. The company reported a 31% year-over-year increase in Monthly Unique Payers.
  • United States Cellular Corporation (NYSE: USM) gained 14.5% to $24.04 following Q4 results.
  • Kinsale Capital Group, Inc. (NASDAQ: KNSL) jumped 13.7% to $332.00 following upbeat Q4 results.
  • Nogin Inc (NASDAQ: NOGN) rose 13.6% to $0.7260 after the company and Seychelles Imports LLC announced an agreement under which Sychelles will utilize Nogin's Customer Data Platform and Marketing Automation and Marketplace Dropship.
  • HubSpot, Inc. (NYSE: HUBS) gained 12.6% to $407.65 after the company reported better-than-expected Q4 results and issued strong guidance for Q1 and FY23.
  • Pediatrix Medical Group, Inc. (NYSE: MD) jumped 11.8% to $16.85 following strong quarterly sales.
  • Inozyme Pharma, Inc.. (NASDAQ: INZY) gained 11.3% to $3.0050. Inozyme Pharma, on Thursday, announced topline pharmacokinetic (PK), pharmacodynamic (PD), and safety data from the ongoing Phase 1/2 trials of INZ-701 in ENPP1 Deficiency and ABCC6 Deficiency (PXE).
  • Satsuma Pharmaceuticals, Inc. (NASDAQ: STSA) gained 9.3% to $1.07.
  • SharpLink Gaming Ltd. (NASDAQ: SBET) rose 7.8% to $0.56.
Losers
  • Arqit Quantum Inc. (NASDAQ: ARQQ) shares dipped 39.7% to $1.5250 after the company announced a $20 million registered direct offering.
  • Universal Electronics Inc. (NASDAQ: UEIC) dropped 29.9% to $17.15 after reporting downbeat Q4 results.
  • Intuitive Machines, Inc. (NASDAQ: LUNR) fell 24% to $33.77.
  • Verde Clean Fuels, Inc. (NASDAQ: VGAS) declined 22.2% to $8.25. Verde recently announced a joint venture with Diamondback Energy.
  • TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) dropped 20.4% to $0.7601.
  • DZS Inc. (NASDAQ: DZSI) fell 20.2% to $9.62 after the company reported worse-than-expected Q4 results.
  • XP Inc. (NASDAQ: XP) fell 17.6% to $13.09 after the company reported Q4 financial results.
  • AXT, Inc. (NASDAQ: AXTI) fell 16.3% to $4.94 after the company reported worse-than-expected Q4 revenue.
  • RE/MAX Holdings, Inc. (NYSE: RMAX) dropped 16.2% to $19.13 following downbeat quarterly results.
  • Cerberus Cyber Sentinel Corporation (NASDAQ: CISO) fell 16.2% to $0.8211. Cerberus Cyber Sentinel terminated its secondary share sale previously announced on February 13.
  • Stem Inc (NYSE: STEM) fell 15.8% to $8.20 after the company reported worse-than-expected Q4 results.
  • Cognex Corporation (NASDAQ: CGNX) shares fell 15.2% to $46.83 after the company reported worse-than-expected Q4 results.
  • Axcella Health Inc (NASDAQ: AXLA) fell 13.8% to $0.62. Axcella shares climbed over 19% on Thursday after the company announced FDA clearance of its IND application to initiate a phase 2b/3 trial in the U.S. for AXA1125.
  • Cooper-Standard Holdings Inc. (NYSE: CPS) dropped 12.3% to $15.50 following weak quarterly results.
  • VolitionRX Ltd (NASDAQ: VNRX) shares fell 12.3% to $1.79 after the company reported pricing of $7.525 million underwritten public offering of common stock.
  • Natural Health Trends Corp. (NASDAQ: NHTC) dropped 12% to $5.89.
  • Boxed Inc (NYSE: BOXD) fell 11.8% to $0.6307 after jumping 63% on Thursday.
  • Applied Therapeutics Inc (NASDAQ: APLT) shares fell 11.3% to $1.0384 after gaining 17% on Thursday. Applied Therapeutics announced sorbitol reduction data from the ongoing global Phase 3 INSPIRE trial of oral AT-007 in approximately 50 patients with SORD Deficiency in the U.S. and Europe.
  • VolitionRx Limited (NASDAQ: VNRX) fell 10.7% to $1.82 after the company announced pricing of a $4.3 million share common stock offering at $1.75 per share.
  • American Axle & Manufacturing Holdings, Inc. (NYSE: AXL) dropped 9.8% to $9.06 following downbeat quarterly earnings.
  • Albemarle Corporation (NYSE: ALB) fell 9.3% to $258.86. Albemarle recently reported better-than-expected Q4 adjusted EPS results.
  • Pop Culture Group Co Ltd (NASDAQ: CPOP) fell 8.7% to $0.9133.
  • Piedmont Lithium Inc. (NASDAQ: PLL) dropped 8.7% to $67.06. Piedmont Lithium and LG Chem signed equity investment and binding offtake agreements.
  • Dropbox, Inc. (NASDAQ: DBX) dropped 8.1% to $22.02 following Q4 results.
  • Ambrx Biopharma Inc - ADR (NYSE: AMAM) fell 7.8% to $2.5630. Ambrx Biopharma shares jumped 56% on Thursday after the company announced initial data from its ongoing Phase 1 APEX-01 trial of ARX517, Ambrx's proprietary anti-PSMA ADC, in prostate cancer patients.
  • Natwest Group PLC - ADR (NYSE: NWG) fell 6.6% to $6.95 after the company reported Q4 financial results.
  • Moderna Inc (NASDAQ: MRNA) shares dropped 6.1% to $161.83 after the company released interim Phase 3 safety and immunogenicity results for its mRNA-1010 influenza candidate, which did not achieve non-inferiority for the Influenza B strains.
Now Read This: Top 5 Tech And Telecom Stocks That Are Set To Fly This Month

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.